Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125487702 | 12548770 | 2 | F | 20160711 | 20160712 | 20160721 | EXP | US-DRREDDYS-USA/USA/16/0081354 | DR REDDYS | KHAN M, KURIAN S, BISHNOI R. ACUTE-ONSET RHABDOMYOLYSIS SECONDARY TO SITAGLIPTIN AND ATORVASTATIN INTERACTION. INT J GEN MED. 2016;9:103-6. | 60.00 | YR | F | Y | 0.00000 | 20160721 | MD | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125487702 | 12548770 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | UNKNOWN | 91650 | 40 | MG | |||||||
| 125487702 | 12548770 | 2 | I | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125487702 | 12548770 | 1 | Hyperlipidaemia |
| 125487702 | 12548770 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125487702 | 12548770 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125487702 | 12548770 | Drug interaction | |
| 125487702 | 12548770 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |